As the family of technologies for treating benign prostatic hyperplasia (BPH) continues to grow, the key to successful outcomes for male patients may well rest on a rather simple tenet: better diagnostic acumen.
As the family of technologies for treating benign prostatic hyperplasia (BPH) continues to grow, the key to successful outcomes for male patients may well rest on a rather simple tenet: better diagnostic acumen.
